Alixia
PrivateLast Round
Early Funding
Sep 1, 2025
Total Funding Raised
$2.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alixia is a biotechnology company that develops therapeutics to combat cancer drug resistance by targeting the tumor ecosystem.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alixia Comparables
Compare Alixia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResistanceBio | 84% | |
| Novasenta | 83% | |
| Incendia Therapeutics | 82% | |
Alixia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 1, 2025 | ||||
| Series A | Jul 23, 2024 | ||||
| Accelerator | Mar 29, 2022 |
Alixia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ZAKA VC | Early Funding |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 379% MoM, from 135 to 646.
Alixia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alixia's valuation, stock price, and market status.